scholarly journals Glicemic control in prepubertal and pubertal patients with diabetes type 1 - a one year ambulatory follow-up

2001 ◽  
Vol 77 (1) ◽  
pp. 41-4
Author(s):  
Marília B. Gomes ◽  
Simone H. Castro ◽  
Tatiana Garfinkel ◽  
Luis Maurício P. Fernandes ◽  
Edna F. Cunha ◽  
...  
2014 ◽  
Vol 125 ◽  
pp. S215
Author(s):  
S. Løseth ◽  
E. Stålberg ◽  
S. Lindal ◽  
R. Jorde ◽  
S.I. Mellgren

1970 ◽  
Vol 28 (5) ◽  
Author(s):  
Maryam Khandan ◽  
Batool Tirgari ◽  
Farokh Abazari ◽  
Mohammad Ali Cheraghi

BACKGROUND: Incidence of diabetes Type 1 in children with non-classic symptoms is one of the reasons for the delay in their follow-up. Failure in its diagnosis by the health professional exposes the mothers tomany challenges. This study was conducted to exploremothers’ experiences in the diagnosis pathway of diabetes Type 1 in children.METHODS: Semi-structured qualitative interviews were conducted with fifteen mothers of children with Type 1 diabetes.theywere selected by the purposefull sampling method.Their child had a medical file in diabetes centers in Kerman, Iran, at least one year has passed of diabetes diagnosis in their child and the maximum age of the child is 14 years. Data were analyzed using content analysis.Three themes and nine sub-themes emerged during dataanalysis.RESULTS: The extracted themes included “presence in the maze path to the child's disease”, “facing the reality of the child's disease”, and “to grin and bear with new conditions”.CONCLUSIONS: According to the finding, these mothers experienced various challenges. Therefore, identification of thesechallenges by health professionals to prevent and decrease of Them, is necessary. 


2018 ◽  
Vol 17 (2) ◽  
pp. 81-88
Author(s):  
Katarzyna Piechowiak ◽  
◽  
Ewelina Politowska ◽  
Paweł Politowski ◽  
Agnieszka Szypowska ◽  
...  

2021 ◽  
pp. 96-103
Author(s):  
L. A. Suplotova ◽  
A. S. Sudnitsyna ◽  
N. V. Romanova

Introduction. Long-term and high-quality glycemic control prevents the development of vascular complications of diabetes type 1 and improves the disease prognosis, significantly increasing life expectancy. A decrease in the quality of life (QOL) of patients with diabetes type 1 is associated with the disease complications development and carbohydrate metabolism status. In connection with the proven advantages of using indicators of time spent in glycemic ranges (TIR, TAR, TBR), the study of their associations with QOL in patients with type 1 diabetes when switching from long-acting analog insulins to insulin degludec is of particular interest.Aims. To assess the quality of life with diabetes type 1 when switching from long-acting analogs to insulin degludec in real world clinical practice.Materials and methods. The study was designed as a prospective, single-center, uncontrolled study. The recruitment of patients with diabetes type 1 who did not achieve the target values of control of carbohydrate metabolism control, who were on therapy with long-acting and ultrashort-acting analog insulin therapy, was carried out in accordance with the matching criteria. The calculation of TIR and TBR was carried out employing the data from professional continuous monitoring of glucose levels and selfmonitoring of blood glucose levels. The SF-36 Health Status Survey was used to assess QoL.Results. The study included 26 patients who met the inclusion criteria and did not have the exclusion criteria. The relationships between TIR, TBR and QoL parameters during insulin degludec therapy were revealed - with vitality, bodily pain, mental health, which demonstrates an increase in QoL mainly due to the mental component of health.Conclusions. Switching patients with type 1 diabetes from long-acting analog insulins to ultra-long-acting analog insulin on an outpatient basis provides an improvement in glycemic control due to HbA1c and TIR, TBR, and also increases QOL satisfaction, mainly due to the mental component of health.


2017 ◽  
Vol 2 (1) ◽  
pp. 33-41
Author(s):  
Elham Hamidi ◽  
Zolfaghar Abyar ◽  
Arezo Homam Zakeri langroudi ◽  
Narges Zamani ◽  
◽  
...  

HORMONES ◽  
2018 ◽  
Vol 17 (3) ◽  
pp. 397-403
Author(s):  
Zadalla Mouslech ◽  
Maria Somali ◽  
Livadas Sarantis ◽  
Daramilas Christos ◽  
Chatzi Alexandra ◽  
...  

2020 ◽  
Vol 41 (10) ◽  
pp. 1181-1189
Author(s):  
Felix W. A. Waibel ◽  
Martin C. Berli ◽  
Viviane Gratwohl ◽  
Kati Sairanen ◽  
Dominik Kaiser ◽  
...  

Background: The contralateral foot in Charcot arthropathy or neuroarthropathy (CN) is subject to increased plantar pressure. To date, the clinical consequences of this pressure elevation are yet to be determined. The aim of this study was to evaluate ulcer and amputation rates of the contralateral foot in CN. Methods: We abstracted the medical records of 130 consecutive subjects with unilateral CN. Rates of contralateral CN development and recurrence, contralateral ulcer development, and contralateral amputations were recorded. Statistical analysis was performed to identify possible risk factors for contralateral CN and ulcer development, and contralateral amputation. Mean follow-up was 6.2 (SD 4) years. Results: After a mean of 2.5 years, 19.2% patients developed contralateral CN. Female gender was associated with contralateral CN development (odds ratio 3.13, 95% confidence interval 1.27, 7.7). Overall, 46.2% patients developed a contralateral ulcer. Among the patients who developed contralateral CN, 60% developed an ulcer. Sanders type 2 at the index foot (midfoot CN) was significantly associated with contralateral ulcer development. Ulcer-free survival (UFS) differed significantly between patients with diabetes type 1 (median UFS 5131 days) and patients with diabetes type 2 (median UFS 2158 days). A total of 25 amputations had to be performed in 22 (16.9%) patients. Three of those 22 patients (2.3%) needed major amputation. Conclusion: Almost 20% of patients developed contralateral CN. Nearly half of people with CN developed a contralateral foot ulceration. Patients with type 2 diabetes had significantly shorter UFS than patients with diabetes type 1. Every sixth patient needed an amputation, with the majority being minor amputations. The contralateral foot should be monitored closely and included in the treatment in patients with CN. Level of Evidence: Level IV, retrospective study.


Author(s):  
Diego Fernandez-Garcia ◽  
Hurtado Eva Aguilera ◽  
Martin Alfonso Arranz ◽  
Aguilera Beatriz Gonzalez ◽  
Jauregui Blanca Gonzalez ◽  
...  

Author(s):  
Nikolitsa Koutroumani ◽  
Ioanna Partsalaki ◽  
Fotini Lamari ◽  
Athina Dettoraki ◽  
Andrea Paola Rojas Gil ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document